Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OralMed Global is a healthcare company dedicated to the early detection and prevention of oral cancer through innovative screening technologies. The company's flagship product, OralMed, is a non-invasive, point-of-care diagnostic tool designed to identify potentially malignant oral lesions at an early stage. By utilizing advanced optical imaging and fluorescence technology, the device assists dental and medical professionals in differentiating between healthy tissue and suspicious areas. OralMed Global aims to improve patient outcomes by facilitating earlier intervention and reducing the mortality rate associated with late-stage oral cancer diagnosis. The company focuses on providing accessible and cost-effective solutions for routine clinical use in dental practices and oncology clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OralMed Global.